informa
/
1 MIN READ
News

Analyst: Genshin Impact surpasses $1 billion on mobile in six months

According to data captured by the analysts at Sensor Tower, Genshin Impact has now surpassed $1 billion on mobile since September 2020.

Genshin Impact has now surpassed $1 billion in player spending on mobile, at least according to the mobile-minded analysts over at Sensor Tower.

According to estimates from the firm, miHiYo's gacha sensation managed to reach that milestone quicker than other recent mobile giants like Pokemon Go or Lineage M and hit $1 billion in less than six months.

However, Sensor Tower's data notably only covers mobile, meaning player spending on PC or PlayStation 4 isn't included in these figures.

The full Sensor Tower report here has a deeper dive into that data. For some highlights, the bulk of that player spending comes from China. Roughly 30 percent of all player spending, or $302 million so far, came from China, followed by $278.3 million in Japan, and $189 million in the United States.

On average, and across all regions, Sensor Tower estimates Genshin impact has generated an average of $5.8 million per day since launch.

Latest Jobs

Disbelief

Hybrid, Cambridge, MA or Chicago, IL
5.31.23
Quality Assurance Lead

Bladework games

Remote (United States)
5.18.23
Senior Gameplay Engineer

High Fidelity, Inc.

Remote
6.2.23
Game Interaction Designer

Fred Rogers Productions

Hybrid (424 South 27th Street, Pittsburgh, PA, USA
5.19.23
Producer - Games & Websites
More Jobs   

CONNECT WITH US

Explore the
Advertise with
Follow us

Game Developer Job Board

Game Developer

@gamedevdotcom

Explore the

Game Developer Job Board

Browse open positions across the game industry or recruit new talent for your studio

Browse
Advertise with

Game Developer

Engage game professionals and drive sales using an array of Game Developer media solutions to meet your objectives.

Learn More
Follow us

@gamedevdotcom

Follow us @gamedevdotcom to stay up-to-date with the latest news & insider information about events & more